This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

J & J Snack Foods Corp.
Coupang, Inc. Class A
Sabra Health Care REIT, Inc.
Charles River Laboratories International, Inc.
Danaos Corporation

J & J Snack Foods Corp.

JJSF

0.00

Coupang, Inc. Class A

CPNG

0.00

Sabra Health Care REIT, Inc.

SBRA

0.00

Charles River Laboratories International, Inc.

CRL

0.00

Danaos Corporation

DAC

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Raymond James analyst David Rodgers upgraded Sabra Health Care REIT Inc (NASDAQ:SBRA) from Underperform to Market Perform. Sabra Health Care closed at $21.08 on Wednesday. See how other analysts view this stock.
  • Deutsche Bank analyst Peter Milliken upgraded Coupang Inc (NYSE:CPNG) from Hold to Buy and cut the price target from $23 to $21.5. Coupang shares closed at $16.00 on Wednesday. See how other analysts view this stock.
  • Freedom Broker analyst Sergey Glinyanov upgraded Danaos Corp (NYSE:DAC) from Hold to Buy and boosted the price target from $140 to $155. Danaos closed at $138.62 on Wednesday. See how other analysts view this stock.
  • Jefferies analyst Scott Marks upgraded J&J Snack Foods Corp (NASDAQ:JJSF) from Hold to Buy and raised the price target from $81 to $101. J&J Snack Foods shares closed at $84.66 on Wednesday. See how other analysts view this stock.
  • JP Morgan analyst Casey Woodring upgraded Charles River (NYSE:CRL) from Neutral to Overweight and boosted the price target from $180 to $310. Charles River shares closed at $260.72 on Wednesday. See how other analysts view this stock.

Considering buying DAC stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.